NASDAQ · XAGE
Healthcare · Biotechnology
$0.17
Up+$0.00 (+0.00%)
Updated Sep 17, 2026, 3:09 AM
SID Score
4.3/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
XAGE does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning XAGE.
XAGE research
Company profile and research snapshot.
LONGEVITY HEALTH HLDGS
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Benzinga · Jul 15, 2025
Longevity Health Holdings announced a merger with plasma collector true Health, causing its stock to surge over 115% on Tuesday. The all-stock transaction will continue trading under XAGE ticker and aims to leverage plasma synergies for bioaesthetic innovation.
Investing.com · Jul 15, 2025
Longevity Health Holdings (XAGE) announced a $59 million all-stock merger with THPlasma, a plasma collection company, expanding into the plasma industry and dropping a previous BioLabs deal. The merger is expected to close in Q4 2025 and provides significant growth potential.
Benzinga · Jul 14, 2025
Longevity Health Holdings has signed a definitive merger agreement with THPlasma, a plasma collection company, in an all-stock transaction. The merger is expected to close in Q4 2025 and will help address the US plasma shortage while providing growth opportunities for both companies.
Benzinga · May 21, 2025
Longevity Health Holdings (XAGE) announced that it has received a favorable decision from the Nasdaq Hearings Panel to continue its listing on Nasdaq, subject to the satisfaction of the Nasdaq initial listing rules for the combined company following the proposed merger with 20/20 BioLabs.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning XAGE.
No results
No recent SID articles mention XAGE.
